Exagen Statistics
NASDAQ: XGNHealth CareMedical SpecialitiesUSD
3.61-0.19 (-5.00%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Exagen by the numbers
Exagen has a market capitalization of $92.1 million based on 25.51M shares outstanding. With trailing EPS of $-0.76, Exagen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 51.0% below its 50-day average and 29.6% below its 200-day average.
Average daily trading volume is 470.43K shares, or about $1.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XGN valuation vs. peer median
| Metric | XGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $92.10M | $77.91M | +18% |
| Avg. volume | 470.43K | 35.62K | +1221% |
Peer median across 8 companies: KEQU, BDSX, SERA, BNR, TLSI, MDXH, AMS, ACON.
Valuation
- Market cap
- $92.10M
- Price / sales (latest FY)
- 1.38
- EPS (TTM)
- $-0.76
- Shares outstanding
- 25.51M
Price and trading
- Previous close
- 3.80
- Open
- 3.77
- Day range
- 3.48 – 3.90
- 52-week range
- 2.59 – 9.22
- 52-week change
- -52.56%
- Beta
- —
- Volume
- 508.83K
- Average volume
- 470.43K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 92.10M
- Forward Pe
- -7.22
- Eps
- -0.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.22
- Week52 Low
- 2.59
- Avg Volume
- 470.43K
- Shares Outstanding
- 25.51M
- Ma50
- 7.36
- Ma200
- 5.13
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -60.85%
- Pct From52w Low
- 39.38%